What are the signs and symptoms of Systemic Lupus Erythematosus (SLE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Lupus is a multisystem autoimmune disease characterized by a wide range of signs and symptoms, including extreme fatigue, joint pain and swelling, a butterfly-shaped rash, skin lesions, fever, headaches, and sensitivity to sunlight, as well as potential kidney problems, blood disorders, and neurological issues 1. The signs and symptoms of lupus can vary greatly between individuals, but common symptoms include:

  • Extreme fatigue
  • Joint pain and swelling
  • A butterfly-shaped rash across the cheeks and nose
  • Skin lesions that worsen with sun exposure
  • Fever
  • Headaches
  • Sensitivity to sunlight
  • Hair loss
  • Fingers and toes that turn white or blue when cold (Raynaud's phenomenon)
  • Shortness of breath
  • Chest pain
  • Dry eyes Lupus can affect multiple organ systems, potentially causing:
  • Kidney problems
  • Blood disorders like anemia or low platelet counts
  • Neurological issues such as memory problems, confusion, or seizures Some patients develop mouth sores, and many experience periods of symptom flares followed by periods of remission. Since lupus mimics many other conditions, diagnosis typically requires a combination of blood tests, physical examination, and medical history review, considering individual, medical, and societal costs, and should be based on a shared patient-physician decision 1. The treatment goals for lupus include long-term patient survival, prevention of organ damage, and optimization of health-related quality of life, which can be achieved through a multidisciplinary approach, including medications like antimalarials, corticosteroids, immunosuppressants, and lifestyle modifications 1.

From the Research

Signs and Symptoms of Lupus

  • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by inflammation and immune-mediated injury to multiple organ systems, including the mucocutaneous, musculoskeletal, hematologic, and kidney systems 2
  • Clinical factors that may be indicative of lupus include fever, cytopenia, rash, arthritis, and proteinuria, which may be indicative of lupus nephritis 2
  • Immunologic measures, such as SLE-specific autoantibodies and low complement levels, are also used to diagnose lupus 2
  • Approximately 40% of people with SLE develop lupus nephritis, and an estimated 10% of people with lupus nephritis develop end-stage kidney disease after 10 years 2
  • Lupus is more prevalent in African American women and women in other ethnic minority groups 3
  • The disease can cause a wide range of clinical presentations resulting from its effect on multiple organ systems, including neonatal, discoid, drug-induced, and systemic lupus erythematosus (SLE) 4

Common Manifestations of Lupus

  • Lupus nephritis is the most common target-organ manifestation and requires individualized care to minimize toxicity 3
  • Musculoskeletal, hematologic, and severe cutaneous lupus frequently require immunosuppression and/or biologic therapy 5
  • Neuropsychiatric manifestations of lupus also require immunosuppression and/or biologic therapy 5
  • Patients with lupus experience a loss of self-tolerance as a result of abnormal immunological function and the production of autoantibodies, which lead to the formation of immune complexes that may adversely affect healthy tissue 4

Treatment and Management of Lupus

  • Hydroxychloroquine is standard of care for SLE and has been associated with a significant reduction in mortality 2
  • Treatments in addition to hydroxychloroquine are individualized, with immunosuppressive agents, such as azathioprine, mycophenolate mofetil, and cyclophosphamide, typically used for treating moderate to severe disease 2
  • Biologic therapies, such as belimumab, voclosporin, and anifrolumab, are also used to treat lupus, particularly in patients with refractory disease 2, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Systemic Lupus Erythematosus.

Annals of internal medicine, 2020

Research

Lupus: an overview of the disease and management options.

P & T : a peer-reviewed journal for formulary management, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.